ES480624A1 - Un metodo para producir antisueros o anticuerpos contra una glicoproteina asociada con el cancer. - Google Patents

Un metodo para producir antisueros o anticuerpos contra una glicoproteina asociada con el cancer.

Info

Publication number
ES480624A1
ES480624A1 ES480624A ES480624A ES480624A1 ES 480624 A1 ES480624 A1 ES 480624A1 ES 480624 A ES480624 A ES 480624A ES 480624 A ES480624 A ES 480624A ES 480624 A1 ES480624 A1 ES 480624A1
Authority
ES
Spain
Prior art keywords
cadet
iac
associated protein
cancer associated
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES480624A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALFERD BENZON AS
Original Assignee
ALFERD BENZON AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALFERD BENZON AS filed Critical ALFERD BENZON AS
Publication of ES480624A1 publication Critical patent/ES480624A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES480624A 1978-05-17 1979-05-16 Un metodo para producir antisueros o anticuerpos contra una glicoproteina asociada con el cancer. Expired ES480624A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK216378 1978-05-17

Publications (1)

Publication Number Publication Date
ES480624A1 true ES480624A1 (es) 1980-08-16

Family

ID=8110498

Family Applications (1)

Application Number Title Priority Date Filing Date
ES480624A Expired ES480624A1 (es) 1978-05-17 1979-05-16 Un metodo para producir antisueros o anticuerpos contra una glicoproteina asociada con el cancer.

Country Status (15)

Country Link
JP (1) JPS5516291A (fr)
AU (1) AU521404B2 (fr)
BE (1) BE876301A (fr)
DE (1) DE2919833A1 (fr)
ES (1) ES480624A1 (fr)
FI (1) FI791551A7 (fr)
FR (1) FR2426055A1 (fr)
GB (1) GB2021593A (fr)
IT (1) IT7968046A0 (fr)
LU (1) LU81273A1 (fr)
NL (1) NL7903854A (fr)
NO (1) NO791643L (fr)
NZ (1) NZ190470A (fr)
PT (1) PT69617A (fr)
SE (1) SE7904276L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2121417A (en) * 1982-02-22 1983-12-21 Carlton Med Prod Antigens and antibodies useful in the detection of cancer
AU569467B2 (en) * 1982-04-07 1988-02-04 Baylor College Of Medicine Immunoglobulin based cancer treating pharmaceutical compositions

Also Published As

Publication number Publication date
FI791551A7 (fi) 1981-01-01
DE2919833A1 (de) 1979-11-29
NO791643L (no) 1979-11-20
IT7968046A0 (it) 1979-05-17
NL7903854A (nl) 1979-11-20
LU81273A1 (fr) 1979-09-10
SE7904276L (sv) 1979-11-18
AU4717279A (en) 1979-11-22
AU521404B2 (en) 1982-04-01
JPS5516291A (en) 1980-02-04
FR2426055A1 (fr) 1979-12-14
GB2021593A (en) 1979-12-05
BE876301A (fr) 1979-11-16
PT69617A (fr) 1979-06-01
NZ190470A (en) 1982-06-29

Similar Documents

Publication Publication Date Title
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
AU642403B2 (en) Method for the use and synthesis of peptides
EP0930366A3 (fr) Domaines de liaison de la protéine serrate
AU3777989A (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
HUT41836A (en) Process for preparing monoclonal antibodies cross-reactive and cross-protecting against p. aeruginosa serotypes
GB2128630A (en) Method of affinity purification employing monoclonal antibodies
EP0517853A4 (en) Method for detection of -i(borrelia burgdorferi), purified antigen thereof and antibody capable of binding therewith
AU1378395A (en) Metal chelators
IL92037A0 (en) Novel family of high affinity,modified antibodies for cancer treatment
CA2080548A1 (fr) Anticorps monoclonaux contre le virus de l'hepatite c
ES480624A1 (es) Un metodo para producir antisueros o anticuerpos contra una glicoproteina asociada con el cancer.
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
IE860758L (en) Anaplasma marginale subunit antigen for vaccination and¹diagnosis
WO1994021812A3 (fr) Molecules de liaison specifiques aux mutants liberes par l'hepatite b
Hudson et al. The use of column-bound B lymphocytes for absorption of antisera to T lymphocyte antigens
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
AU1626492A (en) Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
AU7955687A (en) Method for purification of antibodies
ZA868673B (en) Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
FI925081A7 (fi) Menetelmä antigeenispesifisen, korkea affiniteetti monokloonisen vasta -aineen valmistamiseksi
AU653182B2 (en) Process for selective removal of salivary alpha-amylase and assay for pancreatic alpha-amylase
MY102245A (en) Purification of antibodies
Fishwild ON THE IMMUNOCHEMICAL AND BIOCHEMICAL DEFINITION OF A NUCLEAR ANTIGEN SCL-70 REACTIVE WITH AUTOANTIBODIES IN PROGRESSIVE SYSTEMATIC SCLEROSIS.
AU3375589A (en) Monoclonal antibodies specific for Hb A1c
FR2411202A1 (fr) Procede d'extraction et de purification de la globuline transporteur d'hormones thyroidiennes tbg